Roche

Another Prospective Alzheimer's Trial
Seeking Alpha
Sat, 10/13/12 - 12:23 pm
solanezumab
Eli Lilly
LY2886721
gantenerumab
Roche
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thu, 10/11/12 - 10:47 am
Alzheimer's disease
Eisai
Forest Labs
JNJ
Pfizer
Eli Lilly
Roche
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Roche teams up with VC in hearing loss project
Pharma Times, UK
Thu, 10/11/12 - 09:32 am
Roche
hearing loss
venture capital
Lilly, Roche Drugs Chosen for Alzheimer Prevention Trial
Bloomberg
Wed, 10/10/12 - 11:32 am
Roche
Alzheimer's disease
Eli Lilly
solanezumab
gantenerumab
Roche Faces New Foe as Boehringer Plans a Rituxan Copy
Bloomberg
Fri, 10/5/12 - 11:27 am
Roche
Rituxan
Boehringer Ingelheim
rheumatoid arthritis
Celgene's Pipeline Offers Catalysts Into 2013
Seeking Alpha
Thu, 10/4/12 - 10:43 am
Celgene
JNJ
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Abraxane
Eli Lilly
Exelixis: First Partnered Program Enters Phase III
Seeking Alpha
Wed, 10/3/12 - 11:20 am
Exelixis
Roche
GSK
GDC-0973
MEK inhibitor
melanoma
Roche declines comment on report of Illumina bid, Bloomberg reports
Yahoo/Fly on the Wall
Tue, 10/2/12 - 11:57 am
Roche
Illumina
M&A
Assessing Peregrine And Seeking Upside In The Space
Seeking Alpha
Mon, 10/1/12 - 12:28 pm
Peregrine Pharmaceuticals
Galena Biopharma
Roche
Sunesis
Roche should pick up AbbVie or BMS, analyst thinks
Fierce Pharma
Fri, 09/28/12 - 10:49 am
AbbVie
Roche
Bristol-Myers Squibb
M&A
Illumina Aims at Roche for Tests Seen Worth $25 Billion
Bloomberg
Fri, 09/28/12 - 10:47 am
Roche
Illumina
DNA sequencing
How Many Pharmas Does It Take to Accelerate Drug Development?
Motley Fool
Tue, 09/25/12 - 10:04 am
drug development
Abbott Labs
AstraZeneca
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
GSK
JNJ
Pfizer
Roche
Sanofi
TransCelerate BioPharma
Roche $5.7 Billion Tumor Drug Sales Hinge on Rival Tests
Bloomberg
Mon, 09/24/12 - 11:04 am
Roche
cancer
Herceptin
Report: Roche's Zelboraf, BMS' Yervoy control their segment
Fierce Pharma
Fri, 09/21/12 - 01:13 pm
Roche
Zelboraf
Bristol-Myers Squibb
Yervoy
melanoma
The Top 5 Big Pharmaceuticals And Their Patent Cliffs
Seeking Alpha
Tue, 09/11/12 - 12:33 pm
patents
patent cliff
GSK
Novartis
Pfizer
Roche
Drugmakers 'could free $33 bln of working capital'-analysts
Reuters
Tue, 09/11/12 - 12:00 pm
Pfizer
Roche
Sanofi
Merck
AstraZeneca: Will New Drugs And CEO Reward Investors?
Seeking Alpha
Tue, 09/11/12 - 10:44 am
AstraZeneca
Roche
Pfizer
Forest Labs
Cubist Pharmaceuticals
Lung Cancer Genomic Mapping Yields New Targets, Researchers Say
Bloomberg
Mon, 09/10/12 - 10:43 am
genomic mapping
lung cancer
Pfizer
Iressa
Roche
Tarceva
Roche expects to keep Rituxan monopoly until 2015
Fierce Pharma
Fri, 09/7/12 - 12:22 pm
Roche
cancer
Rituxan
biosimilars

Pages